| | | | | | | | | | | | | | | | | | | | | | |
Ownership Document
|
| Schema Version: X0306 |
| Document Type: 4 |
| Period of Report: 8/22/22 |
| Not Subject to Section 16: 0 |
| Issuer: |
| Issuer CIK: 1681682 |
| Issuer Name: ENDRA Life Sciences Inc. |
| Issuer Trading Symbol: NDRA |
| Reporting Owner: |
| Reporting Owner ID: |
| | Owner CIK: 1706297 |
| | Owner Name: Thornton Michael Milos |
| Reporting Owner Address: |
| | Owner Street 1: 3600 GREEN COURT, SUITE 350 |
| | Owner Street 2: |
| | Owner City: ANN ARBOR |
| | Owner State: MI |
| | Owner ZIP Code: 48105 |
| | Owner State Description: |
| Reporting Owner Relationship: |
| | Is Director? No |
| | Is Officer? Yes |
| | Is Ten Percent Owner? No |
| | Is Other? No |
| | Officer Title: Chief Technology Officer |
| Non-Derivative Table: |
| Non-Derivative Transaction: |
| | Security Title: |
| | | Value: Common Stock |
| | Transaction Date: |
| | | Value: 8/22/22 |
| | Deemed Execution Date: |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: P |
| | | Equity Swap Involved? No |
| | Transaction Timeliness: |
| | | Value: |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 20,000 |
| | | Transaction Price Per Share: |
| Value: 0.27 |
| | | Transaction Acquired-Disposed Code: |
| Value: A |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 352,775 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| Footnotes: |
| Remarks: |
| Owner Signature: |
| Signature Name: /s/ Michael M. Thornton by Mark Busch, attorney-in-fact |
| Signature Date: 8/24/22 |
